Publication | Closed Access
MEK-ERK inhibition potentiates WAY-600-induced anti-cancer efficiency in preclinical hepatocellular carcinoma (HCC) models
11
Citations
18
References
2016
Year
HepatologyMedicineMek-erk InhibitionPharmacologyLiver CancerWay-600-induced Anti-cancer EfficiencyPreclinical Hepatocellular CarcinomaAnti-cancer AgentOncologyCell BiologyHepatocellular CarcinomaTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1